Sarah Cannon Research Institute
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Research_Institute
|
| gptkbp:affiliated_with |
gptkb:HCA_Healthcare
|
| gptkbp:clinical_trial |
gptkb:immunotherapy
gptkb:surgery genetic studies radiation therapy chemotherapy targeted therapy combination therapies biomarker studies health disparities research quality of life studies survivorship studies novel drug development palliative care studies preventive studies screening studies |
| gptkbp:collaborates_with |
pharmaceutical companies
|
| gptkbp:educational_programs |
gptkb:cancer_treatment
clinical research cancer prevention |
| gptkbp:focuses_on |
cancer research
|
| gptkbp:founded_by |
gptkb:Sarah_Cannon
|
| gptkbp:has_partnerships_with |
academic institutions
community organizations research organizations |
| gptkbp:has_programs_in |
hematology
surgical oncology medical oncology radiation oncology |
| gptkbp:has_publications |
medical journals
clinical research journals oncology journals |
| gptkbp:has_research_areas |
gptkb:Oncology
gptkb:Kaposi's_sarcoma pediatric oncology gastrointestinal cancer head and neck cancer neuro-oncology clinical trials for rare cancers genitourinary cancer gynecologic cancer |
| https://www.w3.org/2000/01/rdf-schema#label |
Sarah Cannon Research Institute
|
| gptkbp:location |
gptkb:Nashville,_Tennessee
|
| gptkbp:offers |
clinical trials
|
| gptkbp:provides |
patient care
|
| gptkbp:receives_funding_from |
government grants
pharmaceutical companies private donations |
| gptkbp:bfsParent |
gptkb:HCA_Healthcare
|
| gptkbp:bfsLayer |
4
|